What Is Testosterone Phenylpropionate?

What Is Testosterone Phenylpropionate?

Testosterone Phenylpropionate is a short acting ester, which has a release time of 1-3 weeks. ‘Testolent’ is the well-known name brand for Testosterone Phenylpropionate. The chemical formula of Testosterone Phenylpropioate is C28H36O3. Testosterone Phenylpropionate is also one of the constituents of Omnadren and Sustanon.

At first, Testosterone Phenylpropionate or Testolent was developed by the Sicomed Pharmaceutical house. At that time, Testosterone Phenylpropionate was difficult to find on the black market, but the recent availability of a variety of powders and the emergence of all the various secretive research laboratories have made Testosterone Phenylpropionate more readily available.

After taking Testosterone Phenylpropionate, it can be converted to both estrogen as well as Dihydrotestosterone (DHT). Testosterone Phenylpropionate maintains its outcomes by encouraging increased nitrogen retention in the muscle. Testosterone Phenylpropionate also raises the degrees of growth factor IGF-1 in the muscle tissue and the liver. Additionally, it also has the capability to raise the activity of satellite cells that play an important role in amending damaged muscle.
Testosterone Phenylpropionate binds to the androgen receptor (AR) and begins gene transcription to carry its message. Androgen receptor (AR) stimulation encourages several AR dependant mechanisms for both muscle gains in addition to fat loss. Testosterone Phenylpropionate also lessens the catabolic glucocorticoid hormones and increases the red blood cell production.

When Testosterone Phenylpropionate changes into estrogen, it causes many serious types of side effects which include gynocomastia, water retention, whereas DHT is often behind hair loss, nausea and prostate enlargement. The cost of Testosterone Phenylpropionate is low because of its recent reemergence on the black market, and high availability. Testosterone Phenylpropionate is going to grow more popular in the coming days.